Precision Biosciences (DTIL) EPS (Basic) Growth (5y) (2023 - 2026)
Precision Biosciences (DTIL) EPS (Basic) Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Precision Biosciences | 226.86 Mn | 139.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.84% |
| Mar 31, 2026 | 49.17% |
| Dec 31, 2025 | 15.69% |
| Sep 30, 2025 | 32.38% |
| Jun 30, 2025 | 37.04% |
| Mar 31, 2025 | 33.25% |
| Dec 31, 2024 | 25.22% |
| Sep 30, 2024 | 21.89% |
| Jun 30, 2024 | 16.46% |
| Mar 31, 2024 | 57.18% |
| Dec 31, 2023 | 52.41% |
| Sep 30, 2023 | 15.51% |
| Jun 30, 2023 | 36.50% |
| Mar 31, 2023 | 29.52% |